Trials / Terminated
TerminatedNCT07438210
Peeling of the Internal Limiting Membrane During Primary Vitrectomy for Retinal Detachment Repair
Effect of Peeling of the Internal Limiting Membrane on Vision Results After Primary Vitrectomy for Retinal Detachment Repair
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- Vienna Institute for Research in Ocular Surgery · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Primary vitrectomy for retinal detachment repair is one of the current methods for surgical treatment of retinal detachment. Additional peeling of the internal limiting membrane (ILM) was reported to successfully prevent development of epiretinal membranes after surgery. The aim of the study is to examine the effect of ILM-Peeling on visual acuity outcomes and on occurrence of postoperative epiretinal membranes.
Detailed description
Retinal detachment is a disorder, usually caused by peripheral retinal breaks, that leads to severe decrease in vision in untreated cases. Primary vitrectomy for retinal detachment repair is one of the current methods for surgical treatment of retinal detachment. Recent retrospective studies support the hypothesis, that peeling of the internal limiting membrane (ILM) is beneficial on postoperative visual acuity and lower rates of occurrence of epiretinal membranes after surgery \[Forlini et al. 2018\]. The aim of the study is to examine the effect of ILM-Peeling on visual acuity outcomes and on occurrence of postoperative epiretinal membranes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | ILM-Peeling | during primary vitrectomy for retinal detachment repair additional ILM-Peeling is performed |
| PROCEDURE | No Peeling | during primary vitrectomy for retinal detachment repair no additional ILM-Peeling is performed |
Timeline
- Start date
- 2019-04-03
- Primary completion
- 2025-01-01
- Completion
- 2025-01-01
- First posted
- 2026-02-27
- Last updated
- 2026-04-15
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT07438210. Inclusion in this directory is not an endorsement.